{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:49:00Z","timestamp":1772160540062,"version":"3.50.1"},"reference-count":13,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["acamh.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Child Adoles Ment Health"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:p>\n                    <jats:bold>Background:\u2002<\/jats:bold>\n                    Psychotropic drugs are not recommended for child and adolescent eating disorders, though they are used empirically for symptomatic treatment and co\u2010morbid conditions. Little is known about rates of prescribing or the beneficial and adverse effects.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective:\u2002<\/jats:bold>\n                    To ascertain rates and outcomes of psychotropic drug prescribing in child and adolescent eating disorder services.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Method:\u2002<\/jats:bold>\n                    Retrospective case note study of eating disorder cases (\n                    <jats:italic>n\u2003<\/jats:italic>\n                    =\n                    <jats:italic>\u2003<\/jats:italic>\n                    308), seen in one year in seven specialist UK services, covering indications, response to treatment, beneficial and adverse effects.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:\u2002<\/jats:bold>\n                    Drugs were prescribed for 27%, (mainly anorexia nervosa), 12% before referral to specialist services. The most commonly prescribed drugs were fluoxetine and olanzapine, but 26 different drugs were used. The most common indications were depression, anxiety and \u2018pseudo\u2010psychotic\u2019 concerns about weight. Drugs were generally well tolerated, but their effectiveness was uncertain.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:\u2002<\/jats:bold>\n                    Non\u2010specialists commonly prescribe psychotropic medication to this vulnerable group without reference to specialist services. Specialists prescribe regularly on empirical grounds, without apparent undue consequences, though these may be under\u2010reported. A prospective clinical trial would further clarify risks and benefits.\n                  <\/jats:p>","DOI":"10.1111\/j.1475-3588.2009.00535.x","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T21:54:39Z","timestamp":1247176479000},"page":"18-22","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Drug Prescribing in Child and Adolescent Eating Disorder Services"],"prefix":"10.1111","volume":"15","author":[{"given":"Simon","family":"Gowers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Claxton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rowlands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anandhi","family":"Inbasagaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippa","family":"Hugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Clark\u2010Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Bryant\u2010Waugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dasha","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Ayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,4]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"CD003391","article-title":"Antidepressants versus placebo for people with bulimia nervosa","volume":"4","author":"Bacaltchuk J.","year":"2003","journal-title":"Cochrane Database System Review"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198502000-00003"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/eat.10115"},{"key":"e_1_2_7_5_1","first-page":"173","article-title":"A Review of medication for children and adolescents with eating disorders","volume":"16","author":"Couturier J.","year":"2007","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-108X(199901)25:1<19::AID-EAT3>3.0.CO;2-3"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2004.08.001"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/00048670701517983"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/10673229309017063"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)01013-1"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/104454603322572660"},{"key":"e_1_2_7_12_1","volume-title":"Eating disorders: Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders","author":"National Collaborating Centre for Mental Health (NCCMH)","year":"2004"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200008000-00002"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.22.2605"}],"container-title":["Child and Adolescent Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1475-3588.2009.00535.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acamh.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1475-3588.2009.00535.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:44:41Z","timestamp":1761759881000},"score":1,"resource":{"primary":{"URL":"https:\/\/acamh.onlinelibrary.wiley.com\/doi\/10.1111\/j.1475-3588.2009.00535.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,4]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1475-3588.2009.00535.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1475-3588.2009.00535.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1649964.1152062","asserted-by":"object"}]},"ISSN":["1475-357X","1475-3588"],"issn-type":[{"value":"1475-357X","type":"print"},{"value":"1475-3588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,4]]},"assertion":[{"value":"2010-01-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}